Elevating Expectations, Broadening Impact: How to Leverage Immunotherapy and EGFR-Targeted Therapy to Improve Outcomes in Unresectable Stage III NSCLC
Chair and Presenters Suresh S. Ramalingam, MD, FACP, FASCO, Kristin Higgins, MD, and Jarushka Naidoo...
56 slides
21
Technology
PeerView